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CC BY-NC-ND license.The scientiﬁc discoveries and technological advances in
diagnostic ultrasonography chronicled in the current issue of
Global Heart are impressive. These advances have now made
highly portable, pocket-sized point-of-care (POC) ultrasound
devices for patient evaluation and management possible.
However, translating investigator-initiated fundamental sci-
entiﬁc discoveries and technological advances into commer-
cially viable diagnostic devices is no simple task. In fact, it is a
well-recognized hurdle for many academic research scientists
that one investigator recently characterized as “the valley that
sits between innovation and commercialization” [1]. Tradi-
tional biomedical research funding is typically exhausted
before the innovative products gain the interest of commercial
investors. Additionally, commercial investors are increasingly
becoming more risk averse with respect to such early-stage
innovation at the same time as drug and device manufac-
turers are reducing their investments at this early stage of
research development. As a result, many promising ideas
never materialize into diagnostic and therapeutic devices and
drugs for patient care.
Recognizing this hurdle, the National Heart, Lung, and
Blood Institute (NHLBI) established the NIH Centers for
Accelerated Innovations (NCAI) program [2]. The goal of this
program is to speciﬁcally address the gap in the commer-
cialization pipeline between scientiﬁc discovery and company
formation in order to support the long-term goal of more
rapidly and effectively moving breakthrough innovations to
available products that will improve patient care and advance
public health [3]. The program speciﬁcally targets technolo-
gies and therapeutics that are poised for proof of concept,
prototype development, and feasibility studies [3]. This pro-
gram holds tremendous promise for transformational change
in the way fundamental scientiﬁc discoveries move from
the laboratory into commercial products [4]. In essence,
providing support for this endeavor will enable biotech-
nology, drug, and device manufacturers to pick up promising
compounds and devices that have been effectively “de-risked”
by academic investigators and get them to market [5].
The 3 NCAI grantees, currently supported by the NHLBI
with grants totaling $31.5 million over 7 years, include the
Boston Biomedical Innovation Center, the Cleveland Clinic
Innovation Center, and the University of California Biomed-
ical Research Acceleration, Integration, and Development
Center for Accelerated Innovation. These centerswill focus on
investigators with research projects that have progressed to a
point where a potential commercial product can be envi-
sioned but additional development efforts are required to
demonstrate feasibility or proof of concept and commercial
potential [3]. Importantly, they will provide educational and
mentoring opportunities in entrepreneurship tailored to the
needs of the research and technological innovator [3]. This
bold initiative is consistent with recommendations made byGLOBAL HEART, VOL. 8, NO. 4, 2013
December 2013: 387-389the Accelerated Innovations Program Working Group that
advised the NHLBI on the framework, structure, key com-
ponents and their functions, as well as critical processes and
resources for success [3].
Another NHLBI Working Group that focused on
onsite tools and technologies for clinical cardiovascular
research and POC convened in June 2012 to discuss the
development and application of POC technologies as tools
for diagnosis and monitoring in the clinical cardiovascular
research setting. The Working Group deﬁned POC testing
as “convenient and immediate clinical diagnostic and lab-
oratory testing at or near the site of patient care using
portable, transportable, handheld instruments and analysis
test kits” [6]. Table 1 provides examples of current active
funding opportunities from the NHLBI to support research
using advanced technologies to develop novel POC de-
vices, tools, and technologies for screening, detection,
evaluation, or treatment of heart, lung, and blood diseases
and sleep disorders.
TheWorldHealthOrganization has identiﬁeddiagnostic,
therapeutic, and assistive devices, tools, andmedicines as 1 of
the 6 principal building blocks of health systems [7].
Strengthening health systems and assuring equitable access,
availability, affordability, and appropriate use of these devices,
especially in low- andmiddle income countries (LMICs), is an
important challenge [8]. In this regard, 2 caveats are worth
emphasizing. First, the pursuit of innovative diagnostic de-
vices should not be at the expense of appropriate use of
existing tools, techniques, and devices. In many settings,
particularly in low-income countries, assuring access to
physical examination and basic diagnostic tools such as the
chest radiograph and electrocardiogram take precedence.
Second, it is best to demonstrate objectively that the use of
these novel devices and technologies leads to health beneﬁt
before their widespread adoption. As an example, the NHLBI
is currently funding the PROMISE (PROspective Multicenter
Imaging Study for Evaluation of Chest Pain) Trial, which has
successfully enrolled 10,000 patients and is testing whether
the use of computed tomography angiography (as compared
to traditional diagnostic approaches) leads to improved clin-
ical outcomes (www.promisetrial.org). Research studies like
these can help avoid inappropriate proliferation and use of
diagnostic tools [9].
In addition to improved access to these devices and
technologies, assuring an adequate and prepared workforce
for the prevention and treatment of cardiovascular diseases
as well as the conduct of locally-relevant basic, clinical, and
population science research is just as crucial. In partnership
with the NIH Fogarty International Center, the NHLBI
supports several global health programs that focus on stra-
tegic research capacity and training needs of LMICs. Two
examples of training programs are the Global Health387
TABLE 1. Funding opportunities to support research using advanced technologies to develop novel point-of-care (POC) devices and
tools and technologies for heart, lung, and blood diseases and sleep disorders
Title FOA Number
Issuing
Institute Released Opens Expires
Activity
Code
Onsite Tools and Technologies for
Heart, Lung, and Blood Clinical
Research Point-of-Care SBIR
(R43/R44)*
RFA-HL-14-011 NHLBI 08/15/2013 09/15/2013 10/16/2015 R43/R44
Developing a Point-of-Care Device
for the Diagnosis of Sickle Cell
Disease in Low Resource Settings
SBIR (R43/ R44)y
RFA-HL-14-010 NHLBI 07/08/2013 09/23/2013 10/24/2015 R43/R44
Technologies To Assess Sleep Health
Status in Populations (R43/R44)z
RFA-HL-14-013 NHLBI 09/13/2013 10/15/2013 11/14/2015 R43/R44
Onsite Tools and Technologies for
Heart, Lung, and Blood Clinical
Research Point-of-Care STTR
(R41/R42){
RFA-HL-14-017 NHLBI 08/15/2013 09/15/2013 10/16/2016 R41/R42
FOA, funding opportunity announcement; SBIR, small business innovation research; STTR, small business technology transfer; RFA, request for
applications.
*http://grants.nih.gov/grants/guide/rfa-ﬁles/RFA-HL-14-011.html.
yhttp://grants.nih.gov/grants/guide/rfa-ﬁles/RFA-HL-14-010.html.
zhttp://grants.nih.gov/grants/guide/rfa-ﬁles/RFA-HL-14-013.html.
{http://grants.nih.gov/grants/guide/rfa-ﬁles/RFA-HL-14-017.html.
Source: NHLBI, http://grants.nih.gov.
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388Program for Fellows and Scholars (GHPFS) and the Medical
Education Partnership Initiative (MEPI). The GHPFS pro-
vides focused mentoring for postdoctoral and doctoral levelFIGURE 1. The National Heart, Lung, and Blood Institute/Un
Country Partner geographical regions.trainees in global health research at established research
training sites in LMICs. The program currently supports 5
support center consortia partnered with 74 research trainingited Health Group Centers of Excellence and Developed
GLOBAL HEART, VOL. 8, NO. 4, 2013
December 2013: 387-389
gWATCHj
sites in 27 LMICs on 4 continents. The MEPI program
provides direct support for developing or expanding and
enhancing transformative models of medical education in
Sub-Saharan Africa by strengthening clinical and research
capacity as part of a retention strategy for faculty of medical
schools and clinical professors [10].
In addition to training programs, the NHLBI also
partners with the Fogarty International Center and other
NIH institutes to support global health research. For
example, the NHLBI currently funds research programs in
Argentina, Ghana, Kenya, and Peru as part of the Global
Alliance for Chronic Disease (GACD) research program in
hypertension prevention and control in 15 LMICs. Each
research project is conducted through a partnership be-
tween investigators in a developed-country institution and
investigators and institutions in an LMIC [11]. Current
projects are funded by 4 of the GACD members, with an
investment of more than $21 million over the next 3 to 5
years [11]. The NHLBI also currently supports research
and training through the NHLBI/United Health Group
Collaborating Centers of Excellence (COEs) (Fig. 1). In this
endeavor, each of the 11 COEs collaborates with research
institutions in developed countries to build research and
training infrastructures and to conduct research to improve
the prevention and treatment of chronic cardiovascular and
lung diseases in their respective country [12]. The research
themes addressed include dietary risks for cardiovascular
diseases, the health impact of indoor air pollution, and the
validation of nonlaboratory screening tools.
The programs and initiatives described here help
support the NIH mission of turning scientiﬁc discoveries
into health. They advance biomedical research at home and
abroad by facilitating rapid commercialization of innova-
tive devices, tools, and medicines to improve patient care.
Most importantly, through funding for research, training,
and education, these programs also invest in the most
valuable asset of all, the men and women who make up the
clinical and biomedical research workforce at home and
abroad.
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